Increased Pulmonary Embolism Risk WIth Rheumatoid Arthritis Drug Tofacitinib - The Cardiology Advisor

Increased Pulmonary Embolism Risk WIth Rheumatoid Arthritis Drug Tofacitinib  The Cardiology Advisor

Tofacitinib dosed at 10 mg twice daily was associated with an increased risk of pulmonary embolism and overall mortality in patients with rheumatoid arthritis.